A different meeting for cardiologists

Author:
Actoverco
Date:
07 October 2019
32

On the occasion of World Heart Day, a one-day symposium was hosted by Actoverco Pharmaceutical Company in coordination with the World Heart Federation and accompanied by specialized cardiovascular associations in Iran and attended by more than 150 physicians and cardiologists.

On the occasion of World Heart Day, a one-day symposium was hosted by Actoverco Pharmaceutical Company in coordination with the World Heart Federation and accompanied by specialized cardiovascular associations in Iran and attended by more than 150 physicians and cardiologists.

According to Actoverco’s Public Relations, the main focus of the meeting was on medical ethics and the necessity of physicians’ focus on patients’ avoidance of harmful habits for heart.

At the beginning of the ceremony, Dr. Fereydoon Nouhi, President of the Iranian Heart Association, stated that the goal of this year’s World Heart Day slogan is to raise awareness and attract public participation in achieving heart health for members of society.

Dr. Azarakhsh Mokri, the psychiatrist, also stated in the program: “Since obesity is one of the influencing factors in the incidence of heart disease, we must admit that quitting addiction to fattening food is more difficult than quitting drug addiction.”

In the rest of this program, seven motivational scientific lectures were presented by prominent cardiologists, psychiatrist, endocrinologists and gastroenterologists.

Reference: PHANA

Related Posts

4R4A0991

Actoverco’s Contribution to the 40th Annual Congress of the Iranian Psychiatric Association

WhatsApp Image 2024-09-23 at 10.46.39 AM

Introduction of Two Progesterone Drugs by Ati Pharmed at the Royan International Congress

Nahale Naraghi honors Pharmacist Day with a special message!

Nahaleh Naraqi honors Pharmacist Day with a special message!

Nahaleh naraqi

Nahaleh Naraqi’s congratulatory message on the occasion of Doctor’s Day

WhatsApp Image 2024-08-10 at 12.07.21

Treatment and Reduction of Menopause Symptoms with New Drugs by “Atipharmed”